1
|
Friesen SA, Hjortland GO, Madsen SJ,
Hirschberg H, Engebraten O, Nesland JM and Peng Q: 5-Aminolevulinic
acid-based photodynamic detection and therapy of brain tumors
(Review). Int J Oncol. 21:577–582. 2002.PubMed/NCBI
|
2
|
Regula J, MacRobert AJ, Gorchein A,
Buonaccorsi GA, Thorpe SM, Spencer GM, Hatfield AR and Bown SG:
Photosensitisation and photodynamic therapy of oesophageal,
duodenal, and colorectal tumours using 5 aminolaevulinic acid
induced protoporphyrin IX - a pilot study. Gut. 36:67–75. 1995.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Ohgari Y, Nakayasu Y, Kitajima S, Sawamoto
M, Mori H, Shimokawa O, Matsui H and Taketani S: Mechanisms
involved in delta-aminolevulinic acid (ALA) -induced
photosensitivity of tumor cells: Relation of ferrochelatase and
uptake of ALA to the accumulation of protoporphyrin. Biochem
Pharmacol. 71:42–49. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Teng L, Nakada M, Zhao SG, Endo Y,
Furuyama N, Nambu E, Pyko IV, Hayashi Y and Hamada JI: Silencing of
ferrochelatase enhances 5-aminolevulinic acid-based fluorescence
and photo-dynamic therapy efficacy. Br J Cancer. 104:798–807. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Valdés PA, Moses ZB, Kim A, Belden CJ,
Wilson BC, Paulsen KD, Roberts DW and Harris BT: Gadolinium- and
5-aminolevulinic acid-induced protoporphyrin IX levels in human
gliomas: An ex vivo quantitative study to correlate protoporphyrin
IX levels and blood-brain barrier breakdown. J Neuropathol Exp
Neurol. 71:806–813. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ennis SR, Novotny A, Xiang J, Shakui P,
Masada T, Stummer W, Smith DE and Keep RF: Transport of
5-aminolevulinic acid between blood and brain. Brain Res.
959:226–234. 2003. View Article : Google Scholar
|
7
|
Stummer W, Stepp H, Möller G, Ehrhardt A,
Leonhard M and Reulen HJ: Technical principles for
protoporphyrin-IX-fluorescence guided microsurgical resection of
malignant glioma tissue. Acta Neurochir (Wien). 140:995–1000. 1998.
View Article : Google Scholar
|
8
|
Stummer W, Stocker S, Wagner S, Stepp H,
Fritsch C, Goetz C, Goetz AE, Kiefmann R and Reulen HJ:
Intraoperative detection of malignant gliomas by 5-aminolevulinic
acid-induced porphyrin fluorescence. Neurosurgery. 42:518–525;
discussion 525–516. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhao S, Wu J, Wang C, Liu H, Dong X, Shi
C, Shi C, Liu Y, Teng L, Han D, et al: Intraoperative
fluorescence-guided resection of high-grade malignant gliomas using
5-aminolevulinic acid-induced porphyrins: A systematic review and
meta-analysis of prospective studies. PLoS One. 8:e636822013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Chaichana KL, Cabrera-Aldana EE,
Jusue-Torres I, Wijesekera O, Olivi A, Rahman M and
Quinones-Hinojosa A: When gross total resection of a glioblastoma
is possible, how much resection should be achieved? World
Neurosurg. 82:e257–e265. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lacroix M, Abi-Said D, Fourney DR,
Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch
SJ, Holland E, et al: A multivariate analysis of 416 patients with
glioblastoma multiforme: Prognosis, extent of resection, and
survival. J Neurosurg. 95:190–198. 2001. View Article : Google Scholar
|
12
|
McGirt MJ, Chaichana KL, Gathinji M,
Attenello FJ, Than K, Olivi A, Weingart JD, Brem H and
Quiñones-Hinojosa AR: Independent association of extent of
resection with survival in patients with malignant brain
astrocytoma. J Neurosurg. 110:156–162. 2009. View Article : Google Scholar
|
13
|
Pichlmeier U, Bink A, Schackert G and
Stummer W; ALA Glioma Study Group: Resection and survival in
glioblastoma multiforme: An RTOG recursive partitioning analysis of
ALA study patients. Neuro Oncol. 10:1025–1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sanai N, Polley MY, McDermott MW, Parsa AT
and Berger MS: An extent of resection threshold for newly diagnosed
glioblastomas. J Neurosurg. 115:3–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Stummer W, Reulen HJ, Meinel T, Pichlmeier
U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B,
Woiciechowsky C, et al ALA-Glioma Study Group: Extent of resection
and survival in glioblastoma multiforme: Identification of and
adjustment for bias. Neurosurgery. 62:564–576; discussion 564–576.
2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Stummer W, Pichlmeier U, Meinel T,
Wiestler OD, Zanella F and Reulen HJ; ALA-Glioma Study Group:
Fluorescence-guided surgery with 5-aminolevulinic acid for
resection of malignant glioma: A randomised controlled multicentre
phase III trial. Lancet Oncol. 7:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Willems PW, Taphoorn MJ, Burger H,
Berkelbach van der Sprenkel JW and Tulleken CA: Effectiveness of
neuronavigation in resecting solitary intracerebral
contrast-enhancing tumors: A randomized controlled trial. J
Neurosurg. 104:360–368. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Senft C, Bink A, Franz K, Vatter H, Gasser
T and Seifert V: Intraoperative MRI guidance and extent of
resection in glioma surgery: A randomised, controlled trial. Lancet
Oncol. 12:997–1003. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Unsgaard G, Selbekk T, Brostrup Müller T,
Ommedal S, Torp SH, Myhr G, Bang J and Nagelhus Hernes TA: Ability
of navigated 3D ultrasound to delineate gliomas and metastases -
comparison of image interpretations with histopathology. Acta
Neurochir (wien). 147:1259–1269; discussion 1269. 2005. View Article : Google Scholar
|
20
|
De Witt Hamer PC, Robles SG, Zwinderman
AH, Duffau H and Berger MS: Impact of intraoperative stimulation
brain mapping on glioma surgery outcome: A meta-analysis. J Clin
Oncol. 30:2559–2565. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Rhoton AL Jr: The lateral and third
ventricles. Neurosurgery. 51(Suppl): S207–S271. 2002. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hayashi Y, Nakada M, Tanaka S, Uchiyama N,
Hayashi Y, Kita D and Hamada J: Implication of 5-aminolevulinic
acid fluorescence of the ventricular wall for postoperative
communicating hydrocephalus associated with cerebrospinal fluid
dissemination in patients with glioblastoma multiforme: A report of
7 cases. J Neurosurg. 112:1015–1019. 2010. View Article : Google Scholar
|
24
|
Tejada-Solís S, Aldave-Orzaiz G,
Pay-Valverde E, Marigil-Sánchez M, Idoate-Gastearena MA and
Diez-Valle R: Prognostic value of ventricular wall fluorescence
during 5-aminolev-ulinic-guided surgery for glioblastoma. Acta
Neurochir (wien). 154:1997–2002; discussion 2002. 2012. View Article : Google Scholar
|
25
|
Miyatake S, Kuroiwa T, Kajimoto Y,
Miyashita M, Tanaka H and Tsuji M: Fluorescence of non-neoplastic,
magnetic resonance imaging-enhancing tissue by 5-aminolevulinic
acid: Case report. Neurosurgery. 61:E1101–E1103; discussion
E1103–E1104. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Utsuki S, Oka H, Sato S, Shimizu S, Suzuki
S, Tanizaki Y, Kondo K, Miyajima Y and Fujii K: Histological
examination of false positive tissue resection using
5-aminolevulinic acid-induced fluorescence guidance. Neurol Med
Chir (Tokyo). 47:210–213; discussion 213–214. 2007. View Article : Google Scholar
|
27
|
Duffau H: Is supratotal resection of
glioblastoma in noneloquent areas possible? World Neurosurg.
82:e101–e103. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Grabowski MM, Recinos PF, Nowacki AS,
Schroeder JL, Angelov L, Barnett GH and Vogelbaum MA: Residual
tumor volume versus extent of resection: Predictors of survival
after surgery for glioblastoma. J Neurosurg. 121:1115–1123. 2014.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Wolbers JG: Novel strategies in
glioblastoma surgery aim at safe, supra-maximum resection in
conjunction with local therapies. Chin J Cancer. 33:8–15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Bae JS, Yang SH, Yoon WS, Kang SG, Hong YK
and Jeun SS: The clinical features of spinal leptomeningeal
dissemination from malignant gliomas. J Korean Neurosurg Soc.
49:334–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Fischer CM, Neidert MC, Péus D, Ulrich NH,
Regli L, Krayenbühl N and Woernle CM: Hydrocephalus after resection
and adjuvant radiochemotherapy in patients with glioblastoma. Clin
Neurol Neurosurg. 120:27–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Montano N, D'Alessandris QG, Bianchi F,
Lauretti L, Doglietto F, Fernandez E, Maira G and Pallini R:
Communicating hydrocephalus following surgery and adjuvant
radiochemotherapy for glioblastoma. J Neurosurg. 115:1126–1130.
2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Saito R, Kumabe T, Jokura H, Shirane R and
Yoshimoto T: Symptomatic spinal dissemination of malignant
astrocytoma. J Neurooncol. 61:227–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
34
|
Vertosick FT Jr and Selker RG: Brain stem
and spinal metastases of supratentorial glioblastoma multiforme: A
clinical series. Neurosurgery. 27:516–521; discussion 521–512.
1990. View Article : Google Scholar : PubMed/NCBI
|
35
|
Grabb PA, Albright AL and Pang D:
Dissemination of supratentorial malignant gliomas via the
cerebrospinal fluid in children. Neurosurgery. 30:64–71. 1992.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Roberts DW, Valdés PA, Harris BT, Fontaine
KM, Hartov A, Fan X, Ji S, Lollis SS, Pogue BW, Leblond F, et al:
Coregistered fluorescence-enhanced tumor resection of malignant
glioma: Relationships between δ-aminolevulinic acid-induced
protoporphyrin IX fluorescence, magnetic resonance imaging
enhancement, and neuropathological parameters. Clinical article. J
Neurosurg. 114:595–603. 2011. View Article : Google Scholar
|
37
|
Stummer W, Tonn JC, Goetz C, Ullrich W,
Stepp H, Bink A, Pietsch T and Pichlmeier U: 5-Aminolevulinic
acid-derived tumor fluorescence: The diagnostic accuracy of visible
fluorescence qualities as corroborated by spectrometry and
histology and postoperative imaging. Neurosurgery. 74:310–319;
discussion 319–320. 2014. View Article : Google Scholar :
|
38
|
Sanai N, Snyder LA, Honea NJ, Coons SW,
Eschbacher JM, Smith KA and Spetzler RF: Intraoperative confocal
microscopy in the visualization of 5-aminolevulinic acid
fluorescence in low-grade gliomas. J Neurosurg. 115:740–748. 2011.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Utsuki S, Oka H, Sato S, Suzuki S, Shimizu
S, Tanaka S and Fujii K: Possibility of using laser spectroscopy
for the intraoperative detection of nonfluorescing brain tumors and
the boundaries of brain tumor infiltrates. Technical note. J
Neurosurg. 104:618–620. 2006. View Article : Google Scholar : PubMed/NCBI
|
40
|
Widhalm G, Kiesel B, Woehrer A,
Traub-Weidinger T, Preusser M, Marosi C, Prayer D, Hainfellner JA,
Knosp E and Wolfsberger S: 5-Aminolevulinic acid induced
fluorescence is a powerful intraoperative marker for precise
histopathological grading of gliomas with non-significant
contrast-enhancement. PLoS One. 8:e769882013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Piccirillo SG, Spiteri I, Sottoriva A,
Touloumis A, Ber S, Price SJ, Heywood R, Francis NJ, Howarth KD,
Collins VP, et al: Contributions to drug resistance in glioblastoma
derived from malignant cells in the sub-ependymal zone. Cancer Res.
75:194–202. 2015. View Article : Google Scholar :
|
42
|
Valdés PA, Kim A, Brantsch M, Niu C, Moses
ZB, Tosteson TD, Wilson BC, Paulsen KD, Roberts DW and Harris BT:
δ-aminolevulinic acid-induced protoporphyrin IX concentration
correlates with histopathologic markers of malignancy in human
gliomas: The need for quantitative fluorescence-guided resection to
identify regions of increasing malignancy. Neurooncol. 13:846–856.
2011.
|
43
|
Valdés PA, Leblond F, Kim A, Harris BT,
Wilson BC, Fan X, Tosteson TD, Hartov A, Ji S, Erkmen K, et al:
Quantitative fluorescence in intracranial tumor: Implications for
ALA-induced PpIX as an intraoperative biomarker. J Neurosurg.
115:11–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
44
|
Wen PY, Macdonald DR, Reardon DA,
Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert
MR, Lassman AB, et al: Updated response assessment criteria for
high-grade gliomas: Response assessment in neuro-oncology working
group. J Clin Oncol. 28:1963–1972. 2010. View Article : Google Scholar : PubMed/NCBI
|
45
|
Cage TA, Pekmezci M, Prados M and Berger
MS: Subependymal spread of recurrent glioblastoma detected with the
intraoperative use of 5-aminolevulinic acid: Case report. J
Neurosurg. 118:1220–1223. 2013. View Article : Google Scholar : PubMed/NCBI
|